479 related articles for article (PubMed ID: 25721930)
1. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system-targeting antihypertensive drugs and risk of vascular cognitive impairment: A meta-analysis.
Zhuang S; Li J; Wang X; Wang HF; Zhang WJ; Wang HY; Xing CM
Neurosci Lett; 2016 Feb; 615():1-8. PubMed ID: 26797651
[TBL] [Abstract][Full Text] [Related]
3. Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
Ashby EL; Kehoe PG
Expert Opin Investig Drugs; 2013 Oct; 22(10):1229-42. PubMed ID: 23800077
[TBL] [Abstract][Full Text] [Related]
4. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.
Zhuang S; Wang HF; Li J; Wang HY; Wang X; Xing CM
Neurosci Lett; 2016 Jun; 624():53-61. PubMed ID: 27163195
[TBL] [Abstract][Full Text] [Related]
6. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
7. The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer's disease: A meta-analysis.
Zhuang S; Wang HF; Wang X; Li J; Xing CM
J Clin Neurosci; 2016 Nov; 33():32-38. PubMed ID: 27475317
[TBL] [Abstract][Full Text] [Related]
8. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
[TBL] [Abstract][Full Text] [Related]
10. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].
Ohrui T
Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease.
Furiya Y; Ryo M; Kawahara M; Kiriyama T; Morikawa M; Ueno S
Alzheimers Dement; 2013 Sep; 9(5):512-8. PubMed ID: 23142434
[TBL] [Abstract][Full Text] [Related]
12. First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.
Wang G; Chen Y; Li L; Tang W; Wright JM
J Hum Hypertens; 2018 Jul; 32(7):494-506. PubMed ID: 29713053
[TBL] [Abstract][Full Text] [Related]
13. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.
Bangalore S; Fakheri R; Toklu B; Messerli FH
BMJ; 2016 Feb; 352():i438. PubMed ID: 26868137
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.
Gard PR
Expert Opin Ther Targets; 2004 Feb; 8(1):7-14. PubMed ID: 14996614
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis.
Daien V; Duny Y; Ribstein J; du Cailar G; Mimran A; Villain M; Daures JP; Fesler P
Am J Hypertens; 2012 Jan; 25(1):126-32. PubMed ID: 21993366
[TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
Ribeiro VT; de Souza LC; Simões E Silva AC
Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
[TBL] [Abstract][Full Text] [Related]
18. The brain RAS and Alzheimer's disease.
Wright JW; Harding JW
Exp Neurol; 2010 Jun; 223(2):326-33. PubMed ID: 19782074
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.
Miyajima A; Yazawa S; Kosaka T; Tanaka N; Shirotake S; Mizuno R; Kikuchi E; Oya M
Ann Surg Oncol; 2015 Oct; 22(11):3751-9. PubMed ID: 25691280
[TBL] [Abstract][Full Text] [Related]
20. Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients.
Chen C; Wang F; Chen P; Jiang J; Cui G; Zhou N; Moroni F; Moslehi JJ; Ammirati E; Wang DW
J Am Heart Assoc; 2020 Nov; 9(21):e017736. PubMed ID: 32807002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
